earticle

Correspondence on Letter regarding “Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances”

Byoung Kuk Jang

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.30 No.2 2024.04 pp.297-298

JCAD, a new potential therapeutic target in cholestatic liver disease

Byoung Kuk Jang

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.30 No.2 2024.04 pp.166-167

High Sodium Intake, as Assessed by Urinary Sodium Excretion, Is Associated with Nonalcoholic Fatty Liver Disease or Sarcopenia

Han Eugene, Kim Mi Kyung, Im Seung-Soon, Kim Hye Soon, Kwon Taeg Kyu, Jang Byoung Kuk

[NRF 연계] 거트앤리버 소화기연관학회협의회 Gut and Liver Vol.17 No.3 2023.05 pp.456-465

Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment

Song Jeong Eun, Kang Min Kyu, Lee Yu Rim, Lee Chang Hyeong, Park Jung Gil, Kweon Young Oh, Tak Won Young, Park Soo Young, Jang Se Young, Hwang Jae Seok, Jang Byoung Kuk, Jang Won Young, Suh Jeong Ill, 정우진, 김병석, Daegu-Gyeongbuk Liver Study Group

[NRF 연계] 거트앤리버 소화기연관학회협의회 Gut and Liver Vol.15 No.4 2021.07 pp.606-615

Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C

Ahn Young-Hwan, Lee Heirim, 김도영, 이혜원, Yu Su Jong, Cho Young Youn, Jang Jeong Won, Jang Byoung Kuk, Kim Chang Wook, Kim Hee Yeon, Park Hana, Cho Hyo Jung, Park Bumhee, Kim Soon Sun, 정재연

[NRF 연계] 거트앤리버 소화기연관학회협의회 Gut and Liver Vol.15 No.3 2021.05 pp.410-419

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?

Byoung Kuk Jang

[NRF 연계] 대한간학회 Clinical and Molecular Hepatology Vol.26 No.3 2020.07 pp.312-314